Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
29.20B
Market cap29.20B
Price-Earnings ratio
33.13
Price-Earnings ratio33.13
Dividend yield
—
Dividend yield—
Average volume
1.65M
Average volume1.65M
High today
$199.24
High today$199.24
Low today
$191.28
Low today$191.28
Open price
$195.01
Open price$195.01
Volume
1.94M
Volume1.94M
52 Week high
$309.35
52 Week high$309.35
52 Week low
$112.65
52 Week low$112.65

Stock Snapshot

The current Illumina(ILMN) stock price is $192.58, with a market capitalization of 29.2B. The stock trades at a price-to-earnings (P/E) ratio of 33.13.

During the trading session on 2026-11-21, Illumina(ILMN) shares reached a daily high of $199.24 and a low of $191.28. At a current price of $192.58, the stock is +0.7% higher than the low and still -3.3% under the high.

Trading volume for Illumina(ILMN) stock has reached 1.94M, versus its average volume of 1.65M.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

ILMN News

MarketWatch 1d
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zacks 1d
RPRX vs. ILMN: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Royalty Pharma (RPRX Quick QuoteRPRX - Free Report) and Illumina...

RPRX vs. ILMN: Which Stock Should Value Investors Buy Now?
Simply Wall St 2d
Illumina Shares Just Moved, So What Is Driving Attention Now?

Illumina (ILMN) is back in focus after the company raised its full year 2026 revenue and earnings guidance, citing strong clinical demand for its sequencing pla...

Illumina Shares Just Moved, So What Is Driving Attention Now?

Analyst ratings

46%

of 24 ratings
Buy
45.8%
Hold
37.5%
Sell
16.7%

More ILMN News

Simply Wall St 4d
How Investors Are Reacting To Illumina Cybersecurity Recalls

Illumina recalled thousands of NextSeq 550Dx, MiSeq Dx and NovaSeq 6000Dx diagnostic instruments after identifying cybersecurity vulnerabilities in data communi...

How Investors Are Reacting To Illumina Cybersecurity Recalls

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.